Table 1.

Subject Characteristics

Diagnosis	Age	Sex	PMI	pH	Cause of death	AS*	MS*
CTL	77	F	17	6.32	cardiomyopathy	none	none
CTL	47	F	24	5.89	pulmonary embolus	none	none
CTL	57	M	27	6.43	ischemic heart disease	none	none
CTL	38	M	46	6.42	trauma	none	none
CTL	68	M	41	6.06	aortic stenosis	none	none
CTL	39	F	65	6.38	mitral valve prolapse	none	none
CTL	56	F	24	5.88	cardiac tamponade	none	none
CTL	67	M	32	6.14	myocardial infarction	none	none
mean/total	56.1 ± 14	4F, 4M	34.5 ± 15	6.2 ± 0.2	suicide: 0/8	0/8	0/8
BD	74	F	45	6.26	drug toxicity	FLU	none
BD	58	F	41	5.68	ischemic heart disease	none	none
BD	59	M	34	4.46	ruptured aorta	none	Li+
BD	38	M	24	6.42	CO poisoning	CPZ	Li+
BD	66	M	17	6.41	aspiration	FLU	none
BD	55	F	52	6.46	unknown	CPZ	Li+
BD	60	F	50	6.08	cardiomyopathy	TRI	Li+
BD	61	M	58	6.44	myocardial infarction	FLU, MEL	VPA
mean/total	58.9 ± 10	4F, 4M	39.1 ± 13	6.3 ± 0.2	suicide: 2/8	6/8	5/8
SCZ	79	F	26	6.27	hypothermia	FLU	none
SCZ	48	F	52	6.21	pulmonary embolus	FLU	Li+
SCZ	57	M	24	6.06	coronary atheroma	FLU, CPZ	none
SCZ	38	M	40	5.52	mediastinitis	HAL	none
SCZ	65	M	41	6.57	ischemic heart disease	FLU	none
SCZ	47	F	50	6.31	pneumonia	RIS	none
SCZ	65	F	50	6.35	ruptured aorta	FLU	none
SCZ	69	M	48	6.44	CO poisoning	HAL	none
mean/total	58.5 ± 14	4F, 4M	41.4 ± 11	6.2 ± 0.3	suicide: 1/8	8/8	1/8

Abbreviations: postmortem interval (PMI), male (M), female (F), control (CTL), bipolar disorder (BD), schizo-phrenia (SCZ), haloperidol (HAL), risperidol (RIS), mellaril (MEL), chlorpromazine (CPZ), fluphenazine (FLU), trifluoperazine (TRI), lithium (Li⁺), valproic acid (VPA), carbon monoxide (CO). Age and DOI are expressed in years.

^*Mood stabilizer (MS) or antipsychotic (AS) treatment at time of death. Data expressed as mean+/- SD